Press Release: Meditope Biosciences : Meditope Receives BioLabs Golden Ticket Award From Sanofi to Advance Bioconjugation Technology Research

Meditope Biosciences, Inc., a biotechnology company developing novel antibody-based cancer products using its proprietary technology, today announced it has received a BioLabs Golden Ticket from Paris-based biopharmaceutical company, Sanofi, to fund Meditope’s lab space.